Literature DB >> 33505806

Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2.

Gajendra Kumar Azad1.   

Abstract

SARS-CoV-2 genon class="Gene">me encodes four structural proteins that include the spike glycoprotein, membrane protein, envelope protein and nucleocapsid phosphoprotein (N-protein). The N-protein interacts with viral genomic RNA and helps in packaging. As SARS-CoV-2 spread to almost all countries worldwide within 2-3 months, it also acquired mutations in its RNA genome. Therefore, this study was conducted with an aim to identify the variations present in N-protein of SARS-CoV-2. Here, we analysed 4,163 reported sequence of N-protein from United States of America (USA) and compared them with the first reported sequence from Wuhan, China. Our study identified 107 mutations that reside all over the N-protein. Further, we show the high rate of mutations in intrinsically disordered regions (IDRs) of N-protein. Our study show 45% residues of IDR2 harbour mutations. The RNA-binding domain (RBD) and dimerization domain of N-protein also have mutations at key residues. We further measured the effect of these mutations on N-protein stability and dynamicity and our data reveals that multiple mutations can cause considerable alterations. Altogether, our data strongly suggests that N-protein is one of the mutational hotspot proteins of SARS-CoV-2 that is changing rapidly and these mutations can potentially interferes with various aspects of N-protein functions including its interaction with RNA, oligomerization and signalling events.
© 2021 Azad.

Entities:  

Keywords:  COVID-19; Infectious disease; Mutations; Nucleocapsid Phosphoprotein (N protein); SARS-CoV-2; USA

Year:  2021        PMID: 33505806      PMCID: PMC7789862          DOI: 10.7717/peerj.10666

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  37 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  Phosphorylation of the porcine reproductive and respiratory syndrome virus nucleocapsid protein.

Authors:  Sarah K Wootton; Raymond R R Rowland; Dongwan Yoo
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 3.  The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy.

Authors:  Rabi Ann Musah
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

4.  Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.

Authors:  Zhuo Zhou; Lili Ren; Li Zhang; Jiaxin Zhong; Yan Xiao; Zhilong Jia; Li Guo; Jing Yang; Chun Wang; Shuai Jiang; Donghong Yang; Guoliang Zhang; Hongru Li; Fuhui Chen; Yu Xu; Mingwei Chen; Zhancheng Gao; Jian Yang; Jie Dong; Bo Liu; Xiannian Zhang; Weidong Wang; Kunlun He; Qi Jin; Mingkun Li; Jianwei Wang
Journal:  Cell Host Microbe       Date:  2020-05-04       Impact factor: 21.023

5.  DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability.

Authors:  Carlos Hm Rodrigues; Douglas Ev Pires; David B Ascher
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

6.  Identification of an epitope of SARS-coronavirus nucleocapsid protein.

Authors:  Ying Lin; Xu Shen; Rui Fu Yang; Yi Xue Li; Yong Yong Ji; You Yu He; Mu De Shi; Wei Lu; Tie Liu Shi; Jin Wang; Hong Xia Wang; Hua Liang Jiang; Jian Hua Shen; You Hua Xie; Yuan Wang; Gang Pei; Bei Fen Shen; Jia Rui Wu; Bing Sun
Journal:  Cell Res       Date:  2003-06       Impact factor: 25.617

7.  Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients.

Authors:  Kai Liu; Ying Chen; Ruzheng Lin; Kunyuan Han
Journal:  J Infect       Date:  2020-03-27       Impact factor: 6.072

8.  Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein.

Authors:  Yu-Sheng Lo; Shing-Yen Lin; Shiu-Mei Wang; Chin-Tien Wang; Ya-Li Chiu; Tai-Huang Huang; Ming-Hon Hou
Journal:  FEBS Lett       Date:  2012-11-22       Impact factor: 4.124

View more
  5 in total

1.  SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats.

Authors:  Miruthula Tamil Selvan; Sachithra Gunasekara; Ping Xiao; Kristen Griffin; Shannon R Cowan; Sai Narayanan; Akhilesh Ramachandran; Darren E Hagen; Jerry W Ritchey; Jennifer M Rudd; Craig A Miller
Journal:  Viruses       Date:  2022-06-01       Impact factor: 5.818

2.  Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins.

Authors:  Boon Zhan Sia; Wan Xin Boon; Yoke Yee Yap; Shalini Kumar; Chong Han Ng
Journal:  F1000Res       Date:  2022-01-06

3.  Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021.

Authors:  Sabrina Jungnick; Bernhard Hobmaier; Lena Mautner; Mona Hoyos; Maren Haase; Armin Baiker; Heidi Lahne; Ute Eberle; Clara Wimmer; Sabrina Hepner; Annika Sprenger; Carola Berger; Alexandra Dangel; Manfred Wildner; Bernhard Liebl; Nikolaus Ackermann; Andreas Sing; Volker Fingerle
Journal:  Euro Surveill       Date:  2021-04

4.  Prevalence and circulation patterns of SARS-CoV-2 variants in European sewage mirror clinical data of 54 European cities.

Authors:  Shelesh Agrawal; Laura Orschler; Selina Schubert; Kira Zachmann; Leo Heijnen; Simona Tavazzi; Bernd Manfred Gawlik; Miranda de Graaf; Gertjan Medema; Susanne Lackner
Journal:  Water Res       Date:  2022-02-05       Impact factor: 11.236

5.  Lipopeptides against COVID-19 RNA-dependent RNA polymerase using molecular docking.

Authors:  Bo Xia; Minyi Luo; Li Pang; Xia Liu; Youjin Yi
Journal:  Biomed J       Date:  2021-12-03       Impact factor: 7.892

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.